¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"shadow cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ÀºÄ£È¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
plasma cell
ÇüÁú¼¼Æ÷
polynucleated cell
¹µÇÙ¼¼Æ÷
prickle cell
°¡½Ã¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷, À¸¶ä¼¼Æ÷
Purkinje cell
1. ½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, 2. Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ìµå¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticuloendothelial cell
±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
rod cell
¸·´ë¼¼Æ÷
round cell
¿øÇü¼¼Æ÷
satellite cell
À§¼º¼¼Æ÷
scavenger cell
û¼Ò¼¼Æ÷
Schwann's cell
½Å°æÁý¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
basal cell adenoma
±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
basosqumaous cell acanthoma
±âÀúÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
cell-associated antibody
¼¼Æ÷ºÎÂøÇ×ü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
Graham cell
±×¶óÇÔ¼¼Æ÷
Granulosa cell
°ú¸³¸·¼¼Æ÷(Î¨Ø£Ø¯á¬øà)
Granulosa cell tumor
°ú¸³¸·¼¼Æ÷Á¾¾ç(Î¨Ø£Ø¯á¬øàðþåË)
H-9 cell line
H-9 ¼¼Æ÷°è
HeLa cell
Çï¶ó¼¼Æ÷.
HeLa cell
Çï¶ó¼¼Æ÷
Heidenhain s cell
ÇÏÀ̵§ÇÏÀμ¼Æ÷.
Henle s cell
Çî·¯¼¼Æ÷.
Hfr cell
°íºóµµÀçÁ¶ÇÕ¼¼Æ÷
Hulle cell
¿ÜÇǼ¼Æ÷
ICSH = interstitial cell stimulating hormone
°£Áú¼¼Æ÷ÀÚ±Ø(Êàòõá¬øàí©Ð½)È£¸£¸ó.
ICSH=£¾interstitial cell stimulating hormone
°£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó.
K cell
K¼¼Æ÷, »ìÇØ¼¼Æ÷
LE cell
LE¼¼Æ÷.
LE cell phenomenon
LE¼¼Æ÷Çö»ó.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
shadow density
À½¿µ³óµµ
shadow density
À½¿µ ¹Ðµµ
shadow hearing
À½¿µÃ»°¢
shadow nucleus
À½¿µÇÙ(ëäç¯ú·).
shadow of calyx
¹æ»ç ½ÅÀå¼úÀÜ¿µ, ½Å¹è(À½)¿µ(ãìÛÊëäç¯).
shadow of iris
ȫ俵(ûöóôç¯).
shadow test
°Ë¿µ±¼Àý°Ë»ç(¹ý)(Ëþç¯Ûö).
shadow tray
À½¿µ¹Ý
shadow, Jungian, definition
±×¸²ÀÚ, ½¦µµ¿ì(À¶ÇÐÆÄ)
summation shadow
ÁßøÀ½¿µ, °¡»êÀ½¿µ
tumor shadow
Á¾¾ç À½¿µ
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
beta cell insulin cell
º£Å¸¼¼Æ÷ Àν´¸°¼¼Æ÷
bronchiolar cell clara cell
¼¼±â°üÁö¼¼Æ÷
cell to cell cooperation
¼¼Æ÷°£ÇùÁ¶ÀÛ¿ë(á¬øàÊàúððàíÂéÄ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½